Warning: The NCBI web site requires JavaScript to function. more...
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB.
Breast Cancer Res. 2005;7(4):R513-21. Epub 2005 May 12.
Related citations
CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Verla-Tebit E, Wang-Gohrke S, Chang-Claude J.
Breast Cancer Res. 2005;7(4):R455-64. Epub 2005 Apr 12.
The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ.
Cancer Res. 1999 Mar 1;59(5):1015-20.
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.
Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S, Graham S, Vena JE, Shields PG.
Breast Cancer Res. 2003;5(2):R45-51. Epub 2003 Jan 29.
CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.
Einarsdóttir K, Rylander-Rudqvist T, Humphreys K, Ahlberg S, Jonasdottir G, Weiderpass E, Chia KS, Ingelman-Sundberg M, Persson I, Liu J, Hall P, Wedrén S.
Breast Cancer Res. 2005;7(6):R890-6. Epub 2005 Sep 14.
CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.
Spurdle AB, Hopper JL, Dite GS, Chen X, Cui J, McCredie MR, Giles GG, Southey MC, Venter DJ, Easton DF, Chenevix-Trench G.
J Natl Cancer Inst. 2000 Oct 18;92(20):1674-81.
The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
Ye Z, Parry JM.
Mutagenesis. 2002 Mar;17(2):119-26.
Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K.
Breast Cancer Res Treat. 2009 Mar;114(2):327-38. Epub 2008 Jul 16.
Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
Shin MH, Lee KM, Yang JH, Nam SJ, Kim JW, Yoo KY, Park SK, Noh DY, Ahn SH, Kim B, Kang D.
Exp Mol Med. 2005 Feb 28;37(1):11-7.
A polymorphism in the CYP17 gene increases the risk of breast cancer.
Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE.
Cancer Res. 1997 Mar 15;57(6):1063-5.
A polymorphism in CYP17 and endometrial cancer risk.
Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I.
Cancer Res. 2001 May 15;61(10):3955-60.
Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.
Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A.
Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1343-8.
CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
Chakraborty A, Murthy NS, Chintamani C, Bhatnagar D, Mohil RS, Sharma PC, Saxena S.
J Hum Genet. 2007;52(2):159-65. Epub 2007 Jan 18.
The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women.
McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG.
J Nutr. 2002 Oct;132(10):3036-41.
CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.
Antognelli C, Del Buono C, Ludovini V, Gori S, Talesa VN, Crinò L, Barberini F, Rulli A.
BMC Cancer. 2009 Apr 20;9:115.
Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.
Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S, Eng SM, Wang Q, Gurvich I, Neugut AI, Santella RM, Ahsan H.
Carcinogenesis. 2008 Apr;29(4):766-71. Epub 2008 Feb 14.
The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
Haiman CA, Stampfer MJ, Giovannucci E, Ma J, Decalo NE, Kantoff PW, Hunter DJ.
Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):743-8.
CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.
Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J.
J Nutr. 2006 Jun;136(6):1596-603.
Association between CYP17 polymorphisms and the development of breast cancer.
Helzlsouer KJ, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Comstock GW, Bell DA.
Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):945-9.
Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.
Cui JS, Spurdle AB, Southey MC, Dite GS, Venter DJ, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL.
Genet Epidemiol. 2003 Apr;24(3):161-72.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on